Glioblastoma Clinical Trials in Minneapolis, Minnesota

3 studies are recruiting for glioblastoma in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

    This is a multicenter, two-arm, randomized, double-blind, placebo-controlled study of Optune® (Tumor Treating Fields at 200 kHz) together with maintenance Temozolomide (TMZ) chemotherapy agent and pembrolizumab compared to Optune® together with maintenance TMZ and placebo in newly diagnosed Gliobla…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota
    Locations
    102 in total
    Run by
    NovoCure GmbH

    See if you can join NCT06556563 on ClinicalTrials.gov

  2. A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

    Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/III response adaptive randomization platform trial designed to evaluate multiple therapies in newly diagnosed (ND) and recurrent GBM. All institutions are enrolling Newly Diagnose…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Allina Health Systems/Abbott Northwestern Hospital, Minneapolis, Minnesota
    Locations
    63 in total
    Run by
    Global Coalition for Adaptive Research

    See if you can join NCT03970447 on ClinicalTrials.gov

  3. First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

    This is a single center, first-in cancer-type phase I clinical trial of FT536 for adult patients with recurrent WHO Grade 4 astrocytoma, irrespective of IDH-mutational status, for which a standard of care repeat craniotomy for gross tumor resection at time of first or second recurrence is achievabl…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Elizabeth C. Neil, MD, Minneapolis, Minnesota
    Run by
    Masonic Cancer Center, University of Minnesota

    See if you can join NCT07560865 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.